- Home
- WST vs BNTX Comparison
WST vs BNTX Comparison
Compare WST & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- BNTX
- Stock Information
- Founded
- WST 1923
- BNTX 2008
- Country
- WST United States
- BNTX Germany
- Employees
- WST N/A
- BNTX N/A
- Industry
- WST Medical/Dental Instruments
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WST Health Care
- BNTX Health Care
- Exchange
- WST Nasdaq
- BNTX Nasdaq
- Market Cap
- WST 23.2B
- BNTX 23.9B
- IPO Year
- WST N/A
- BNTX 2019
- Fundamental
- Price
- WST $333.19
- BNTX $113.77
- Analyst Decision
- WST Strong Buy
- BNTX Strong Buy
- Analyst Count
- WST 5
- BNTX 15
- Target Price
- WST $437.75
- BNTX $143.50
- AVG Volume (30 Days)
- WST 482.3K
- BNTX 630.9K
- Earning Date
- WST 02-13-2025
- BNTX 11-04-2024
- Dividend Yield
- WST 0.25%
- BNTX N/A
- EPS Growth
- WST N/A
- BNTX N/A
- EPS
- WST 6.74
- BNTX N/A
- Revenue
- WST $2,876,400,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- WST N/A
- BNTX N/A
- Revenue Next Year
- WST $6.08
- BNTX N/A
- P/E Ratio
- WST $49.37
- BNTX N/A
- Revenue Growth
- WST N/A
- BNTX N/A
- 52 Week Low
- WST $265.00
- BNTX $76.53
- 52 Week High
- WST $413.70
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- WST 58.32
- BNTX 48.60
- Support Level
- WST $325.33
- BNTX $109.52
- Resistance Level
- WST $335.53
- BNTX $115.34
- Average True Range (ATR)
- WST 7.63
- BNTX 4.35
- MACD
- WST 0.36
- BNTX -0.72
- Stochastic Oscillator
- WST 76.56
- BNTX 26.76
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.